{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:22:06Z","timestamp":1768972926841,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clnu.2024.12.033","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:48:12Z","timestamp":1736038092000},"page":"136-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Xiaoning","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaofeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanying","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-4911","authenticated-orcid":false,"given":"Yueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.12.033_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.04.074","article-title":"Preparing for the NASH epidemic: a call to action","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.12.033_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2024.12.033_bib3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.12.033_bib6","article-title":"Global burden of common cancers attributable to metabolic risks from 1990 to 2019","volume":"4","author":"Xing","year":"2023","journal-title":"Med (N Y)"},{"key":"10.1016\/j.clnu.2024.12.033_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.numecd.2022.11.007","article-title":"MAFLD is associated with increased all-cause mortality in low cardiovascular-risk individuals but not in intermediate to high-risk individuals","volume":"33","author":"Chen","year":"2023","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2024.12.033_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A\u00a0phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","volume":"20","author":"Younossi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.849854","article-title":"Edaravone modulates neuronal GPX4\/ACSL4\/5-LOX to promote recovery after spinal cord injury","volume":"10","author":"Pang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.clnu.2024.12.033_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2014.05.051","article-title":"Edaravone protected PC12 cells against MPP(+)-cytoxicity via inhibiting oxidative stress and up-regulating heme oxygenase-1 expression","volume":"343","author":"Cheng","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.clnu.2024.12.033_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115165","article-title":"Inhibition of autophagy and RIP1\/RIP3\/MLKL-mediated necroptosis by edaravone attenuates blood spinal cord barrier disruption following spinal cord injury","volume":"165","author":"Xu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clnu.2024.12.033_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","article-title":"Edaravone: a new drug approved for ALS","volume":"171","author":"Rothstein","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clnu.2024.12.033_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2004.09.018","article-title":"Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats","volume":"42","author":"Tsuji","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib18","doi-asserted-by":"crossref","first-page":"16668","DOI":"10.1021\/acsnano.3c02877","article-title":"Encapsulation of an antioxidant in redox-sensitive self-assembled albumin nanoparticles for the treatment of hepatitis","volume":"17","author":"Yasuda","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.clnu.2024.12.033_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/jpet.103.053595","article-title":"Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin","volume":"307","author":"Kono","year":"2003","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clnu.2024.12.033_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/1071576031000136586","article-title":"A\u00a0free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury","volume":"37","author":"Nakamoto","year":"2003","journal-title":"Free Radic Res"},{"key":"10.1016\/j.clnu.2024.12.033_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-009-0034-4","article-title":"Antifibrotic effect of edaravone in rat liver cirrhosis induced by dimethylnitrosamine","volume":"9","author":"Tanaka","year":"2009","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110251","article-title":"Edaravone protects against liver fibrosis progression via decreasing the IL-1\u03b2 secretion of macrophages","volume":"368","author":"Zhao","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.clnu.2024.12.033_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081117","article-title":"Edaravone attenuated angiotensin II-induced atherosclerosis and abdominal aortic aneurysms in apolipoprotein E-deficient mice","volume":"12","author":"Uchida","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.clnu.2024.12.033_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103812","article-title":"Dysfunctional oxidative phosphorylation shunts branched-chain amino acid catabolism onto lipogenesis in skeletal muscle","volume":"39","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.clnu.2024.12.033_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","article-title":"Integrative study of diet-induced mouse models of NAFLD identifies PPAR\u03b1 as a sexually dimorphic drug target","volume":"71","author":"Smati","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2024.12.033_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.12.033_bib27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2024.12.033_bib28","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.08.027","article-title":"In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores","volume":"151","author":"Schwimmer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.12.033_bib29","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1111\/bph.15099","article-title":"Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21\/PGC-1\u03b1 pathway","volume":"177","author":"Wu","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clnu.2024.12.033_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2006.05.040","article-title":"Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis","volume":"191","author":"Xi","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2024.12.033_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.phrs.2006.02.003","article-title":"Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats","volume":"54","author":"Saini","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnu.2024.12.033_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clnu.2024.12.033_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clnu.2024.12.033_bib34","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2024.12.033_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2024.12.033_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clnu.2024.12.033_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","article-title":"AMPK Re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development","volume":"28","author":"Boudaba","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clnu.2024.12.033_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2024.12.033_bib39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2024.12.033_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.12.033_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154241","article-title":"Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-\u03baB\/NLRP3 signaling pathway","volume":"104","author":"Deng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clnu.2024.12.033_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.05.047","article-title":"Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice","volume":"811","author":"Zhang","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clnu.2024.12.033_bib44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1253\/circj.72.800","article-title":"Inhibition of neointimal hyperplasia development by MCI-186 is correlated with downregulation of nuclear factor-kappaB pathway","volume":"72","author":"Radhakrishnan","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.clnu.2024.12.033_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.clnu.2024.12.033_bib46","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/DDDT.S144807","article-title":"Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor","volume":"11","author":"Zhang","year":"2017","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.clnu.2024.12.033_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbrc.2017.10.165","article-title":"Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-\u03b21\/Smad3 signaling","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:37:16Z","timestamp":1740368236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424004746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"alternative-id":["S0261561424004746"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.12.033","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}